Clinique Honoré Cave

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Macular degeneration5 trials
• Diabetic eye disease2 trials
• Obesity1 trial

Phase

• Phase 22 trials
• Phase 32 trials
• Phase 41 trial

Status

• Recruiting3 trials
• Active, not recruiting2 trials
• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• AbbVie2 trials
• Hoffmann-La Roche2 trials
• Centre Hospitalier Universitaire De Dijon1 trial
• Clinique Pasteur1 trial
• Laboratoires Kol1 trial

Running trials

• Recruiting

  Evaluating Aganirsen Eye Drops to Reduce the Number of Aflibercept Injections in Wet Age-Related Macular Degeneration Patients.

  2026-526775-27-00· Phase 2· Laboratoires Kol· Source

• Recruiting

  A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD

  NCT06847542· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

  NCT05476926· Hoffmann-La Roche· Source

• Active, not recruiting

  Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

  NCT05407636· Phase 3· AbbVie· Source

• Recruiting

  Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema

  2024-513983-24-00· Phase 4· Centre Hospitalier Universitaire De Dijon· Source

• Enrolling by invitation

  Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy

  NCT03999801· Phase 2· AbbVie· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration3 recruiting
• Diabetic eye disease1 recruiting

Closed trials

• Completed

  Oxygenation Procedure for Obese Patients During Intubation in the Operating Room

  NCT06914401· Clinique Pasteur· Source